You just read:

Optimer Pharmaceuticals Announces Combined Data From Fidaxomicin Phase 3 Trials for the Treatment of Clostridium difficile Infection (CDI) Presented at IDSA

News provided by

Optimer Pharmaceuticals, Inc.

Oct 23, 2010, 11:00 ET